[Simultaneous test of ventricular function and myocardial perfusion during exercise with a new agent labelled with Tc99m]

Autor: N, Pérez Baliño, V, Sporn, L L, Holman, A, Sosa Liprandi, O, Masoli, A, Mitta, L, Camin, S, Castiglia, K, McKusick

Publikováno v: Medicina. 47(2)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2dacd57fbc13694887c140652ccf929f
https://pubmed.ncbi.nlm.nih.gov/3073294

Anaesthesia mumps presenting as an airway emergency requiring tracheal intubation.

Autor: Kerner V; Department of Anaesthesia Oxford University Hospitals Oxford UK., Holman L; Department of Anaesthesia Oxford University Hospitals Oxford UK.

Publikováno v: Anaesthesia reports [Anaesth Rep] 2023 Jun 25; Vol. 11 (1), pp. e12238. Date of Electronic Publication: 2023 Jun 25 (Print Publication: 2023).

Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults.

Autor: Ledgerwood JE; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Coates EE; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Yamshchikov G; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Saunders JG; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Holman L; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Enama ME; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., DeZure A; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Lynch RM; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Gordon I; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Plummer S; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Hendel CS; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Pegu A; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Conan-Cibotti M; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Sitar S; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Bailer RT; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Narpala S; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., McDermott A; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Louder M; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., O'Dell S; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Mohan S; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA., Pandey JP; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA., Schwartz RM; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Hu Z; Biostatistics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Koup RA; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Capparelli E; School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, San Diego, CA, USA., Mascola JR; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Graham BS; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Publikováno v: Clinical and experimental immunology [Clin Exp Immunol] 2015 Dec; Vol. 182 (3), pp. 289-301. Date of Electronic Publication: 2015 Sep 24.

Polyandrous females found fitter populations.

Autor: Power DJ; Division of Evolution, Ecology & Genetics, Research School of Biology, Australian National University, Canberra, ACT, Australia., Holman L

Publikováno v: Journal of evolutionary biology [J Evol Biol] 2014 Sep; Vol. 27 (9), pp. 1948-55. Date of Electronic Publication: 2014 Jul 09.

A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults.

Autor: Ledgerwood JE; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 40 Convent Drive, Bethesda, MD 20892-3017, United States. Ledgerwood@mail.nih.gov, Costner P, Desai N, Holman L, Enama ME, Yamshchikov G, Mulangu S, Hu Z, Andrews CA, Sheets RA, Koup RA, Roederer M, Bailer R, Mascola JR, Pau MG, Sullivan NJ, Goudsmit J, Nabel GJ, Graham BS

Publikováno v: Vaccine [Vaccine] 2010 Dec 16; Vol. 29 (2), pp. 304-13. Date of Electronic Publication: 2010 Oct 27.